Harald Sourij
@haraldsou
Professor for interdisciplinary metabolic medicine, Medical University of Graz
ID: 1560640255786528769
19-08-2022 14:50:32
25 Tweet
81 Followers
81 Following
#Herzschwäche nach Infarkt: Unser Forschungsteam berichtet von einer neuen Therapieoption, mit der die Pumpleistung des Herzes nach einem #Herzinfarkt möglichst erhalten werden kann Harald Sourij Details: medunigraz.at/news/detail/me…
Proud of our very successful information event for our outstanding study participants in the COVAC-DM, INTERFAST-2, ULTRFLEXI-1 and EMMY trials. Took place yesterday Med Uni Graz Campus. Harald Sourij Othmar Moser Felix Aberer Alexander Norbert Tripolt
Our new COVAC-DM paper is now available in Diabetes, Obesity and Metabolism. Thanks to Med Uni Graz and FWF ! Othmar Moser Harald Harald Sourij Alexander Nick Oliver Marga Dominguez-Villar Lab
Check out our Ultraflexi-1 study presented by Harald Sourij at SO22 (exercise) at 1:15 pm (PS: exercise works🏃🏼♀️🏃🏼♀️🏃🏼♀️) EASD Dom Michael Riddell, PhD Paul Coker, MSc Kamil @Nerdabetic Richard Bracken Katarina Braune, MD
Is there a link between HbA1c & VO2max in people with T1D? Let me know your thoughts - via our meta-analysis: weak correlation Michael Riddell, PhD Paul Coker, MSc Tadej Battelino Max Eckstein @MM640G Richard Bracken Jane Yardley Deutsche Diabetes Gesellschaft Österreichische Diabetes Gesellschaft Harald Sourij mdpi.com/2218-1989/12/1…
#IntermittentFasting over 12 weeks is a safe and feasible dietary option to ameliorate glycemic control while reducing total daily insulin dose and body weight in #insulin treated people with type 2 #diabetes #T2D #weightloss Diabetes Care, a research journal of the ADA 🌟 diabetesjournals.org/care/article/d…
Interfast-2 study shows 3 nonconsecutive days of intermittent fasting a week over 12 weeks is safe & effective in reducing HbA1c & body weight in people w/ insulin-treated T2 diabetes when insulin doses on fasting days are adjusted ADA Professional Publications Read Here➡️doi.org/10.2337/dc22-1…
Appendix 1: Great team to work with: Harald Sourij (CI), study team: Alexander Felix Aberer Clinical Trials Unit for Metabolic Medicine Norbert Tripolt Med Uni Graz
Diabetische Nephropathie 2023 - Gemeinsames Positionspapier von ÖGN und Österreichische Diabetes Gesellschaft ist online! uploads-ssl.webflow.com/62a1addc5dabff…
Höchstleistungen trotz DM1?! Markus Sauer selbst sagt "Höchstleistungen WEGEN DM1". Viel Erfolg bei deinem bewundernswerten Marathon- Abenteuer! Julia Mader 🇺🇦🇦🇹🏳️🌈🇪🇺🇮🇱 & Harald Sourij, passt auf ihn auf 😀
Metabolite alterations predict type 2 diabetes-associated cardiovascular events: buff.ly/3EEUZXm Jessica Regan @Laurentrubymd Harald Sourij Robert Mentz, MD Rob McGarrah Svati Shah Canadian VIGOUR Centre #Cardiology #Metabolism
For adults w/ heart failure & an ICD , can an SGLT2i ⬇️ a person’s risk of ventricular arrhythmias? Based on this double-blind RCT of ertugliflozin vs. placebo, it appears it can! 💓💊 eviden.cc/476qaIL Harald Sourij Martin Benedikt Daniel Scherr #ESCardio
Thank you to all of our amazing colleagues and friends that helped to put this EASD ISPAD position statement together! We are excited to finally share these guidelines 🙌🏼 Diabetologia Michael Riddell, PhD DovcK Othmar Moser
Are adventure camps safe for adolescents living with T1D? Happy to share our recently published data from the DIACAMP study Biosensors. mdpi.com/2079-6374/14/9… YD_AUSTRIA Felix Aberer Julia Mader 🇺🇦🇦🇹🏳️🌈🇪🇺🇮🇱 Othmar Moser Harald Sourij Österreichische Diabetes Gesellschaft
In this double-blind RCT of adults with heart failure and a defibrillator, the SGLT2i ertugliflozin led to an ~80% relative risk reduction of VTach/VFib. 💊👩🔬 Full article by Martin Benedikt et al.: eviden.cc/476qaIL Harald Sourij Daniel Scherr
